ESR1 and breast cancer: Some researchers confirmed increasing concentrations of estrogen, as well as elevated expression of estrogen receptor alpha (ERα), significantly elevated SERPINB9 level in breast cancer cells, thus effectively deactivated granzyme B and mitigated NK cell-induced cell death.